scispace - formally typeset
Journal ArticleDOI

Antituberculosis drugs: ten years of research.

Yves L. Janin
- 01 Apr 2007 - 
- Vol. 15, Iss: 7, pp 2479-2513
Reads0
Chats0
TLDR
This review presents the drugs currently used in antituberculosis treatments and the most advanced compounds undergoing clinical trials and provides a description of their mechanism of action along with other series of inhibitors known to act on related biochemical targets.
About
This article is published in Bioorganic & Medicinal Chemistry.The article was published on 2007-04-01. It has received 477 citations till now. The article focuses on the topics: Tuberculosis & Antibacterial agent.

read more

Citations
More filters
Journal ArticleDOI

Biological activities of hydrazone derivatives.

TL;DR: There has been considerable interest in the development of novel compounds with anticonvulsant, antidepressant, analgesic, antiinflammatory, antiplatelet, antimalarial, antimicrobial, antimycobacterial, antitumoral, vasodilator, antiviral and antischistosomiasis activities.
Journal ArticleDOI

Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.

TL;DR: In this Review, recent efforts to fight TB will be described, specifically focusing on how drug discovery could combat the resistance and persistence that make TB worthy of the moniker 'The Great White Plague'.
Journal ArticleDOI

targetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis

TL;DR: A comprehensive in silico target identification pipeline, targetTB, for Mycobacterium tuberculosis, which provides rational schema for drug target identification that are likely to have high rates of success, which is expected to save enormous amounts of money, resources and time in the drug discovery process.
References
More filters
Journal ArticleDOI

DNA topoisomerases: structure, function, and mechanism.

TL;DR: Surprisingly, despite little or no sequence homology, both type IA and type IIA topoisomerases from prokaryotes and the typeIIA enzymes from eukaryotes share structural folds that appear to reflect functional motifs within critical regions of the enzymes.
Journal ArticleDOI

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

TL;DR: A diarylquinoline, R207910, is identified that potently inhibits both drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro and mutants selected in vitro suggest that the drug targets the proton pump of adenosine triphosphate (ATP) synthase.
Journal ArticleDOI

The Envelope of Mycobacteria

TL;DR: Differences in mycolic acid structure may affect the fluidity and permeability of the bilayer, and may explain the different sensitivity levels of various mycobacterial species to lipophilic inhibitors.
Journal ArticleDOI

Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics

TL;DR: The functional implications of the high-resolution 30S crystal structure are described, and details of the interactions between the 30S subunit and its tRNA and mRNA ligands are inferred, which lead to a model for the role of the universally conserved 16S RNA residues A1492 and A1493 in the decoding process.
Related Papers (5)